LifeTech Scientific Corporation Files Director List with HKEX

Reuters11-21
LifeTech Scientific Corporation Files Director List with HKEX

LifeTech Scientific Corporation has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The Board is led by Xie Yuehui, who serves as Chairman and Chief Executive Officer. Other executive directors include Liu Jianxiong (Executive Vice President, Chief Financial Officer, and Company Secretary), Wu Liping, Fang Yu, and Feng Xiaoling. Jiang Feng serves as a non-executive director. The independent non-executive directors are Wang Wansong, Zhou Luming, and Chen Dongxia. The company has established three Board committees. The Audit Committee is chaired by Chen Dongxia, with Zhou Luming and Wang Wansong as members. The Remuneration Committee is chaired by Wang Wansong, with Xie Yuehui and Chen Dongxia as members. The Nomination Committee is chaired by Zhou Luming, with Xie Yuehui, Feng Xiaoling, Wang Wansong, and Chen Dongxia as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeTech Scientific Corporation published the original content used to generate this news brief on November 21, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment